Pimafutsin 30g of 2% cream in the tube

The instruction for medical use of Pimafutsin® medicine the Trade name of Pimafutsin® the International not patent name Natamitsin Lekarstvennaya a form Cream for external use of 2%, 30 g Structure of 1 g of drug contains active agent - natamitsin 20 mg, excipients: cetostearyl alcohol, sodium lauryl sulfate, propylene glycol, wax on the basis of cetyl ethers, decyl oleate (tsetiol), methylparahydroxybenzoate, propilparagidroksibenzoat, water the Pharmacotherapeutic group cleaned the Description Cream of white or slightly yellow color Antifungal drugs for topical administration. ATX D01AA02 code the Pharmacological Pharmacokinetics Natamitsin properties – drug of local action, is practically not soaked up through the uninjured skin. Pharmacodynamics Antifungal half-yen antibiotic of fungicide action. Natamitsin connects sterols of cellular membranes, breaking their integrity and functions that leads to death of microorganisms. The majority of a pathogenic barmy fungi, especially Candida spp are sensitive to a natamitsin. Dermatophytes are less sensitive. The resistance to a natamitsin in clinical practice does not occur among barmy mushrooms. Indications - infections of skin and mucous, caused by sensitive barmy, yeast-like mushrooms and dermatophytes, including balanoposthites, otomycoses the Route of administration and doses In candidiases of skin and mucous cream put one or several, usually to 4 times a day. In candidosis mycosis of external acoustical pass the struck surface is greased with cream one or a little, usually to 4 times a day. Before drug use the ear is cleaned. After use of drug place a turunda from natural material (cotton, wool) in acoustical pass. Пимафуцин® in shape cream is used for treatment of candidosis damage of genitals of the partner. In a balanoposthitis cream is applied on affected areas of skin by one or several, usually to 4 times a day. Duration of a course of treatment is established individually by the doctor. After disappearance of symptoms of a disease five more days are recommended to continue treatment. Side effects - slight irritation, burning sensation (in the place of use) Contraindications - hypersensitivity to drug components Medicinal interactions Medicinal interactions are not described. Children can appoint the special instructions Use in pediatrics of Pimafutsin®, since the neonatality period. Pregnancy and the period of a lactation use of Pimafutsina® during pregnancy and a lactation is possible. The feature of influence of medicine on ability to drive the car or other potentially dangerous mechanisms does not influence. Overdose Now about cases of overdose of the drug Pimafutsin® it was not reported. The form of release and packing On 30 g of drug place in an aluminum tuba with the screwing-up cover. On 1 tuba together with the instruction for medical use place in a cardboard pack. To Store storage conditions at a temperature from 15 wasps up to 25 wasps. To store out of children's reach! 3 years not to apply a period of storage after the expiration date specified on packing. Prescription status According to the prescription the Name and the country of the Temmler Italia manufacturing organization of Neuter. L., the Via Industri's 2 business, 20061 Karugat, Milan, Italy the Name and the country of the owner of the registration certificate of LEO of Pharm of A/S, 55, Industriparken, DK-2750 Ballerup, Denmark the Address of the organization accepting in the territory of the Republic of Kazakhstan claims from consumers on quality of the products (goods) responsible for post-registration observation of safety of medicine: Responsible person: Anastasia Mamedova, a menenger on registration Mamyr 1, 29, quarter 188, e-mail of M_nastasiya@mail.ru, info.ru@leo-pharma.comtelefon +7 7012080139